Table 3 Distribution of the Pathological characterization amoung the studies group patients
Type of pathology | Number | Percentage |
|---|---|---|
Malignant | ||
• IDC II | 26 | 43.3 % |
• ILC III | 4 | 6.7 % |
• Metastatic HCC | 3 | 5 % |
• Undifferentiated Carcinoma | 2 | 3.3 % |
Benign | ||
• Fibroadenoma | 16 | 26.7 % |
• Granuloma | 4 | 6.7 % |
• Inflammatory lesions | 3 | 5 % |
• Fibrocystic disease | 2 | 3.3 % |